101 results
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:22am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:21am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:19am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
S-8 POS
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Registration of securities for employees (post-effective amendment)
9:18am
Plan,
2019 Employee Stock Purchase Plan
(Full Title of the Plan)
Shinji Nitanda
Secretary
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard … for issuance under the 2019 Plan, and 160,000 shares of Common Stock for issuance under the 2019 Employee Stock Purchase Plan (the “ESPP”).
Registration
SC 13E3/A
EX-99
STSA
Satsuma Pharmaceuticals Inc
8 Jun 23
Going private transaction (amended)
9:16am
Date (as applicable, a “CVR Payment Date”), pay the aggregate CVR Payment Amount for any non-Employee CVR Holders through the Rights Agent … (for the account of the non-Employee CVR Holders), by wire transfer of immediately available funds to such account as may be designated by the Rights Agent
8-K
EX-3.2
tl9e3qus8ricqu nee
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
8-K
608q2wzcqntfqa 2j
8 Jun 23
Termination of a Material Definitive Agreement
9:13am
SC 14D9
fvxut6x1w06cui3z0o2
5 May 23
Tender offer solicitation
8:17am
10-K/A
4vuqd
28 Apr 23
Annual report (amended)
4:08pm
8-K
EX-10.1
wwsi12t hp5en5p5
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.1
gfti73
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-2.2
ngc d61jqg74bqzfpjzl
17 Apr 23
SNBL to Acquire Satsuma Pharmaceuticals
6:34am
8-K
EX-1.1
eo03 umltzzjio
3 Nov 22
Entry into a Material Definitive Agreement
4:45pm
424B5
wgwr00jobgh q7av
3 Nov 22
Prospectus supplement for primary offering
4:42pm